Press Releases on March 31, 2025 - EIN Presswire - Press Release Distribution Service

Published on March 31, 2025 - 20:05 GMT

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, with a …

Distribution channels: Business & Economy, Technology ...

Published on March 31, 2025 - 20:05 GMT

Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights

– Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial – – Registrational Phase 3 RECOVER-2 trial initiation for brilaroxazine expected mid-2025 – – Full data …

Distribution channels: Business & Economy, Technology ...

Published on March 31, 2025 - 20:05 GMT

Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements

Record Gross Revenue: Achieved record annual gross revenue of $46.0 million, representing a 32% increase from $34.9 million in 2023. Fourth Quarter Results: Gross revenue reached an all-time quarterly high of $13.3 million in Q4 2024, marking a 20% …

Distribution channels: Business & Economy, Shipping, Storage & Logistics ...

Published on March 31, 2025 - 20:05 GMT

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; …

Distribution channels: Business & Economy, Technology ...

Published on March 31, 2025 - 20:05 GMT

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027 Strengthened cash position expected to support the Company through first substantive data readout in …

Distribution channels:

Published on March 31, 2025 - 20:05 GMT

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 31, 2025 - 20:05 GMT

Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for ...

BOSTON and ATHENS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced that the Company’s Co-Founder and Chief Scientific Officer, Dr. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 31, 2025 - 20:05 GMT

Progress Announces First Quarter 2025 Financial Results

Annualized Recurring Revenue ("ARR") of $836 million Grew 48% year-over-year Revenue of $238 million Grew 29% year-over-year ShareFile Integration Underway BURLINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted …

Distribution channels: Business & Economy, IT Industry ...

Published on March 31, 2025 - 20:05 GMT

Revolution Medicines to Participate in April 2025 Investor Conferences

REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on March 31, 2025 - 20:05 GMT

Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-...

– Rademikibart demonstrated rapid onset of action with significant improvements in lung function observed at one week and maintained through 24 weeks – – In patients with eosinophilic-driven asthma (≥300 eosinophils/µL) receiving rademikibart for 24 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 31, 2025 - 20:05 GMT

Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results

Q4 Sequential Revenue Growth of 43% Driven by New Products and Technologies, and 131% Year over Year New OEM and Distributor Relationships to Equip New Campers and RVs with Advanced Lithium-Ion Batteries Began Shipping e360 Home Energy Storage Solutions …

Distribution channels: Business & Economy ...

Published on March 31, 2025 - 20:05 GMT

Pathfinder Bancorp, Inc. Declares Dividend

OSWEGO, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- James A. Dowd, President and CEO of Pathfinder Bancorp, Inc., the bank holding company of Pathfinder Bank (NASDAQ: PBHC) (listing: PathBcp), has announced that the Company has declared a cash dividend of $0. …

Distribution channels: Banking, Finance & Investment Industry ...

Published on March 31, 2025 - 20:05 GMT

Applied Digital Sets Fiscal Third Quarter 2025 Conference Call for Monday, April 14, 2025, at 5:00 p.m. Eastern Time

DALLAS, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 31, 2025 - 20:05 GMT

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

- Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® capsule, to subcutaneous administration of PG-102 - - Announced preclinical data demonstrating successful oral …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 31, 2025 - 20:05 GMT

Birchtech Reports Fourth Quarter 2024 Financial Results

Company Drives Fourth Quarter 2024 Revenues of $5.6 Million; Leverages World-Class Activated Carbon Expertise to Launch New Water Purification Business CORSICANA, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (" …

Distribution channels: Business & Economy ...

Published on March 31, 2025 - 20:05 GMT

Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in ...

RENO, Nev., March 31, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling, today announced key achievements from 2024 and outlined progress for 2025 as the Company delivered critical technical …

Distribution channels: Business & Economy, Electronics Industry ...

Published on March 31, 2025 - 20:05 GMT

MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update

Addison, TX, March 31, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today provides an update on operations through and subsequent to …

Distribution channels: Environment, Technology ...

Published on March 31, 2025 - 20:05 GMT

Equity Stock Transfer teams up with Newsmax Inc. for historic IPO opening on New York Stock Exchange’s main board

New York, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Equity Stock Transfer, LLC, a fully independent SEC registered transfer agent, today announced it is processing nearly 25,000 separate transaction requests from Newsmax investors through DRS (the direct …

Distribution channels: ...

Published on March 31, 2025 - 20:05 GMT

Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating ...

Webcast scheduled for Tuesday, April 1, 2025 at 8:00 AM ET. BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 31, 2025 - 20:05 GMT

Open Lending Reports Fourth Quarter and Full Year 2024 Financial Results

AUSTIN, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...